{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:29:50Z","timestamp":1791660590253,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 AG056589"],"award-info":[{"award-number":["K24 AG056589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189961"],"award-info":[{"award-number":["UG1CA189961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016223","name":"Wilmot Cancer Institute, University of Rochester Medical Center","doi-asserted-by":"publisher","award":["GR532432"],"award-info":[{"award-number":["GR532432"]}],"id":[{"id":"10.13039\/100016223","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00520-024-08877-6","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T01:01:23Z","timestamp":1726707683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of polypharmacy and potentially inappropriate medications on physical functional decline among older adults with advanced cancer receiving systemic treatment"],"prefix":"10.1007","volume":"32","author":[{"given":"Mostafa R.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Juba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Culakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Cacciatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Jensen-Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Mohile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ramsdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"8877_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348","journal-title":"CA Cancer J Clin"},{"key":"8877_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan F, Wehling M (2021) Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med 12:443\u2013452","journal-title":"Eur Geriatr Med"},{"key":"8877_CR3","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1634\/theoncologist.2019-0406","volume":"25","author":"MR Mohamed","year":"2019","unstructured":"Mohamed MR, Ramsdale E, Loh KP et al (2019) Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis. Oncologist 25:e94\u2013e108","journal-title":"Oncologist"},{"key":"8877_CR4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","volume":"22","author":"M Delara","year":"2022","unstructured":"Delara M, Murray L, Jafari B et al (2022) Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr 22:601","journal-title":"BMC Geriatr"},{"key":"8877_CR5","unstructured":"Varghese D, Ishida C, Haseer Koya H (2023) Polypharmacy. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Cecilia Ishida declares no relevant financial relationships with ineligible companies. Disclosure: Hayas Haseer Koya declares no relevant financial relationships with ineligible companies: StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC"},{"key":"8877_CR6","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1093\/oncolo\/oyac053","volume":"27","author":"E Ramsdale","year":"2022","unstructured":"Ramsdale E, Mohamed M, Yu V et al (2022) Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment. Oncologist 27:e580\u2013e588","journal-title":"Oncologist"},{"key":"8877_CR7","doi-asserted-by":"crossref","first-page":"e22034","DOI":"10.1200\/JCO.2018.36.15_suppl.e22034","volume":"36","author":"MR Mohamed","year":"2018","unstructured":"Mohamed MR, Mohile SG, Xu H et al (2018) Associations of medication measures and geriatric impairments with chemotherapy dose intensity in older adults with advanced cancer: a University of Rochester NCI Community Oncology Research Program study. J Clin Oncol 36:e22034","journal-title":"J Clin Oncol"},{"key":"8877_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B (2020) Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc 21:181\u2013187","journal-title":"J Am Med Dir Assoc"},{"key":"8877_CR9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/gerona\/glaa128","volume":"76","author":"LJ Chen","year":"2021","unstructured":"Chen LJ, Trares K, Laetsch DC, Nguyen TNM, Brenner H, Sch\u00f6ttker B (2021) Systematic review and meta-analysis on the associations of polypharmacy and potentially inappropriate medication with adverse outcomes in older cancer patients. J Gerontol A Biol Sci Med Sci 76:1044\u20131052","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"8877_CR10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/10781552211012038","volume":"28","author":"DC Guven","year":"2022","unstructured":"Guven DC, Kavgaci G, Aktepe OH et al (2022) The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy. J Oncol Pharm Pract 28:785\u2013793","journal-title":"J Oncol Pharm Pract"},{"key":"8877_CR11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/1049909118824031","volume":"36","author":"K Morio","year":"2019","unstructured":"Morio K, Maeda I, Yokota I et al (2019) Risk factors for polypharmacy in elderly patients with cancer pain. Am J Hosp Palliat Care 36:598\u2013602","journal-title":"Am J Hosp Palliat Care"},{"key":"8877_CR12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11912-017-0632-3","volume":"19","author":"LR Hersh","year":"2017","unstructured":"Hersh LR, Beldowski K, Hajjar ER (2017) Polypharmacy in the geriatric oncology population. Curr Oncol Rep 19:73","journal-title":"Curr Oncol Rep"},{"key":"8877_CR13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2014.58.7550","volume":"33","author":"G Nightingale","year":"2015","unstructured":"Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A (2015) Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol 33:1453\u20131459","journal-title":"J Clin Oncol"},{"key":"8877_CR14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","volume":"151","author":"MH Beers","year":"1991","unstructured":"Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825\u20131832","journal-title":"Arch Intern Med"},{"key":"8877_CR15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"American Geriatrics Society Beers Criteria Update Expert P","year":"2012","unstructured":"American Geriatrics Society Beers Criteria Update Expert P (2012) American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616\u2013631","journal-title":"J Am Geriatr Soc"},{"key":"8877_CR16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11096-022-01506-4","volume":"45","author":"M Murphy","year":"2023","unstructured":"Murphy M, Bennett K, Wright M et al (2023) Potentially inappropriate prescribing in older adults with cancer receiving specialist palliative care: a retrospective observational study. Int J Clin Pharm 45:174\u2013183","journal-title":"Int J Clin Pharm"},{"key":"8877_CR17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jgo.2021.02.021","volume":"12","author":"AH Lavan","year":"2021","unstructured":"Lavan AH, O\u2019Mahony D, O\u2019Mahony D, Gallagher P (2021) Potentially inappropriate medication (PIM) use and severe drug interactions (SDIs) in older adults with cancer. J Geriatr Oncol 12:872\u2013880","journal-title":"J Geriatr Oncol"},{"key":"8877_CR18","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/cncr.31403","volume":"124","author":"MS Karuturi","year":"2018","unstructured":"Karuturi MS, Holmes HM, Lei X et al (2018) Potentially inappropriate medication use in older patients with breast and colorectal cancer. Cancer 124:3000\u20133007","journal-title":"Cancer"},{"key":"8877_CR19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jgo.2014.07.001","volume":"5","author":"LK Saarelainen","year":"2014","unstructured":"Saarelainen LK, Turner JP, Shakib S et al (2014) Potentially inappropriate medication use in older people with cancer: prevalence and correlates. J Geriatr Oncol 5:439\u2013446","journal-title":"J Geriatr Oncol"},{"key":"8877_CR20","doi-asserted-by":"crossref","unstructured":"Ramsdale E, Mohamed M, Yu V, Otto E, Juba K, Awad H, Moorthi K, Plumb S, Patil A, Vogelzang N, Dib E (2022) Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment. Oncol 27(7):e580\u2013e588","DOI":"10.1093\/oncolo\/oyac053"},{"key":"8877_CR21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jgo.2020.10.018","volume":"12","author":"G Nightingale","year":"2021","unstructured":"Nightingale G, Battisti NML, Loh KP et al (2021) Perspectives on functional status in older adults with cancer: an interprofessional report from the International Society of Geriatric Oncology (SIOG) nursing and allied health interest group and young SIOG. J Geriatr Oncol 12:658\u2013665","journal-title":"J Geriatr Oncol"},{"key":"8877_CR22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2340\/165019778416125132","volume":"16","author":"B Brorsson","year":"1984","unstructured":"Brorsson B, Asberg KH (1984) Katz index of independence in ADL. Reliability and validity in short-term care. Scand J Rehabil Med 16:125\u2013132","journal-title":"Scand J Rehabil Med"},{"key":"8877_CR23","first-page":"343","volume":"17","author":"C Graf","year":"2008","unstructured":"Graf C (2008) The Lawton instrumental activities of daily living (IADL) scale. Medsurg Nurs 17:343\u2013344","journal-title":"Medsurg Nurs"},{"key":"8877_CR24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jamaoncol.2019.4728","volume":"6","author":"SG Mohile","year":"2020","unstructured":"Mohile SG, Epstein RM, Hurria A et al (2020) Communication with older patients with cancer using geriatric assessment: a cluster-randomized clinical trial from the National Cancer Institute Community Oncology Research Program. JAMA Oncol 6:196\u2013204","journal-title":"JAMA Oncol"},{"key":"8877_CR25","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s11606-019-05106-3","volume":"34","author":"A Katsimpris","year":"2019","unstructured":"Katsimpris A, Linseisen J, Meisinger C, Volaklis K (2019) The association between polypharmacy and physical function in older adults: a systematic review. J Gen Intern Med 34:1865\u20131873","journal-title":"J Gen Intern Med"},{"key":"8877_CR26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.6004\/jnccn.2020.7628","volume":"19","author":"MR Mohamed","year":"2021","unstructured":"Mohamed MR, Ramsdale E, Loh KP et al (2021) Association of polypharmacy and potentially inappropriate medications with physical functional impairments in older adults with cancer. J Natl Compr Canc Netw 19:267\u2013274","journal-title":"J Natl Compr Canc Netw"},{"key":"8877_CR27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H et al (2021) Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. The Lancet 398:1894\u20131904","journal-title":"The Lancet"},{"key":"8877_CR28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.oraloncology.2012.01.004","volume":"48","author":"YJ Liu","year":"2012","unstructured":"Liu YJ, Zhu GP, Guan XY (2012) Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma. Oral Oncol 48:554\u2013559","journal-title":"Oral Oncol"},{"issue":"67","key":"8877_CR29","first-page":"674","volume":"2019","author":"American Geriatrics Society","year":"2019","unstructured":"American Geriatrics Society (2019) Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2019(67):674\u2013694","journal-title":"J Am Geriatr Soc"},{"key":"8877_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17512433.2020.1697676","volume":"13","author":"D O'Mahony","year":"2020","unstructured":"O\u2019Mahony D (2020) STOPP\/START criteria for potentially inappropriate medications\/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol 13:15\u201322","journal-title":"Expert Rev Clin Pharmacol"},{"key":"8877_CR31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11096-021-01346-8","volume":"44","author":"A Abbas","year":"2022","unstructured":"Abbas A, Al-Shaibi S, Sankaralingam S et al (2022) Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex(\u00ae) and Lexicomp(\u00ae): a retrospective observational study. Int J Clin Pharm 44:348\u2013356","journal-title":"Int J Clin Pharm"},{"key":"8877_CR32","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/eurjpc\/zwab044","volume":"29","author":"L Rinaldo","year":"2022","unstructured":"Rinaldo L, Caligari M, Acquati C et al (2022) Functional capacity assessment and Minimal Clinically Important Difference in post-acute cardiac patients: the role of Short Physical Performance Battery. Eur J Prev Cardiol 29:1008\u20131014","journal-title":"Eur J Prev Cardiol"},{"key":"8877_CR33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1532-5415.2006.00701.x","volume":"54","author":"S Perera","year":"2006","unstructured":"Perera S, Mody SH, Woodman RC, Studenski SA (2006) Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 54:743\u2013749","journal-title":"J Am Geriatr Soc"},{"key":"8877_CR34","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jamda.2020.09.038","volume":"22","author":"SA Welch","year":"2021","unstructured":"Welch SA, Ward RE, Beauchamp MK, Leveille SG, Travison T, Bean JF (2021) The Short Physical Performance Battery (SPPB): a quick and useful tool for fall risk stratification among older primary care patients. J Am Med Dir Assoc 22:1646\u20131651","journal-title":"J Am Med Dir Assoc"},{"key":"8877_CR35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ije\/dyaa213","volume":"50","author":"PWG Tennant","year":"2021","unstructured":"Tennant PWG, Murray EJ, Arnold KF et al (2021) Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations. Int J Epidemiol 50:620\u2013632","journal-title":"Int J Epidemiol"},{"key":"8877_CR36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3414\/ME10-01-0026","volume":"49","author":"A Ziegler","year":"2010","unstructured":"Ziegler A, Vens M (2010) Generalized estimating equations. Notes on the choice of the working correlation matrix. Methods Inf Med 49:421\u2013425 (discussion 6-32)","journal-title":"Methods Inf Med"},{"key":"8877_CR37","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jgo.2021.01.009","volume":"12","author":"G Nightingale","year":"2021","unstructured":"Nightingale G, Mohamed MR, Holmes HM et al (2021) Research priorities to address polypharmacy in older adults with cancer. J Geriatr Oncol 12:964\u2013970","journal-title":"J Geriatr Oncol"},{"key":"8877_CR38","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1200\/OP.20.00681","volume":"17","author":"HD Klepin","year":"2021","unstructured":"Klepin HD, Sun CL, Smith DD et al (2021) Predictors of unplanned hospitalizations among older adults receiving cancer chemotherapy. JCO Oncol Pract 17:e740\u2013e752","journal-title":"JCO Oncol Pract"},{"key":"8877_CR39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1186\/s12877-023-04471-3","volume":"23","author":"C Bandidwattanawong","year":"2023","unstructured":"Bandidwattanawong C, Rattanaserikulchai P, Jetsadavanit N (2023) Polypharmacy and potentially-inappropriate medications are prevalent in the elderly cancer patients receiving systemic cancer therapy and they co-relate with adverse outcomes. BMC Geriatr 23:775","journal-title":"BMC Geriatr"},{"key":"8877_CR40","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.21.00195","volume":"39","author":"MA Flannery","year":"2021","unstructured":"Flannery MA, Culakova E, Canin BE, Peppone L, Ramsdale E, Mohile SG (2021) Understanding treatment tolerability in older adults with cancer. J Clin Oncol 39:2150\u20132163","journal-title":"J Clin Oncol"},{"key":"8877_CR41","doi-asserted-by":"crossref","unstructured":"Outlaw D, Dai C, Al-Obaidi M, Harmon C, Giri S, Bhatia S, Williams GR (2022) The association of polypharmacy with functional status impairments, frailty, and health-related quality of life in older adults with gastrointestinal malignancy-Results from the Cancer and Aging Resilience Evaluation (CARE) registry. J Geriatr Oncol 13(5):624\u2013628","DOI":"10.1016\/j.jgo.2021.12.010"},{"key":"8877_CR42","doi-asserted-by":"crossref","first-page":"101772","DOI":"10.1016\/j.jgo.2024.101772","volume":"15","author":"Z Yue","year":"2024","unstructured":"Yue Z, Xue X, Qian J (2024) The association between polypharmacy and health-related quality of life among older adults with prostate cancer. J Geriatr Oncol 15:101772","journal-title":"J Geriatr Oncol"},{"key":"8877_CR43","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/jgs.12942","volume":"62","author":"RJ Maggiore","year":"2014","unstructured":"Maggiore RJ, Dale W, Gross CP et al (2014) Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc 62:1505\u20131512","journal-title":"J Am Geriatr Soc"},{"key":"8877_CR44","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/1078155218788698","volume":"25","author":"C Paksoy","year":"2019","unstructured":"Paksoy C, \u00d6zkan \u00d6, Ustaalio\u011flu BB et al (2019) Evaluation of potentially inappropriate medication utilization in elderly patients with cancer at outpatient oncology unit. J Oncol Pharm Pract 25:1321\u20131327","journal-title":"J Oncol Pharm Pract"},{"key":"8877_CR45","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/cncr.34642","volume":"129","author":"MR Mohamed","year":"2023","unstructured":"Mohamed MR, Mohile SG, Juba KM et al (2023) Association of polypharmacy and potential drug-drug interactions with adverse treatment outcomes in older adults with advanced cancer. Cancer 129:1096\u20131104","journal-title":"Cancer"},{"key":"8877_CR46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s12877-022-03358-z","volume":"22","author":"J Kudelka","year":"2022","unstructured":"Kudelka J, Geritz J, Welzel J et al (2022) What contributes most to the SPPB and its subscores in hospitalized geriatric patients: an ICF model-based approach. BMC Geriatr 22:668","journal-title":"BMC Geriatr"},{"key":"8877_CR47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12883-020-01843-9","volume":"20","author":"M Bruderer-Hofstetter","year":"2020","unstructured":"Bruderer-Hofstetter M, Sikkes SAM, M\u00fcnzer T, Niedermann K (2020) Development of a model on factors affecting instrumental activities of daily living in people with mild cognitive impairment \u2013 a Delphi study. BMC Neurol 20:264","journal-title":"BMC Neurol"},{"key":"8877_CR48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/gerona\/glt192","volume":"69","author":"A Koyama","year":"2014","unstructured":"Koyama A, Steinman M, Ensrud K, Hillier TA, Yaffe K (2014) Long-term cognitive and functional effects of potentially inappropriate medications in older women. J Gerontol A Biol Sci Med Sci 69:423\u2013429","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"8877_CR49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13825585.2019.1597008","volume":"27","author":"JS Passler","year":"2020","unstructured":"Passler JS, Kennedy RE, Clay OJ et al (2020) The relationship of longitudinal cognitive change to self-reported IADL in a general population. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 27:125\u2013139","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"key":"8877_CR50","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jgo.2019.02.004","volume":"10","author":"AL Couderc","year":"2019","unstructured":"Couderc AL, Boulahssass R, Nouguer\u00e8de E et al (2019) Functional status in a geriatric oncology setting: A review. J Geriatr Oncol 10:884\u2013894","journal-title":"J Geriatr Oncol"},{"key":"8877_CR51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jclinepi.2010.07.005","volume":"64","author":"BM Buurman","year":"2011","unstructured":"Buurman BM, van Munster BC, Korevaar JC, de Haan RJ, de Rooij SE (2011) Variability in measuring (instrumental) activities of daily living functioning and functional decline in hospitalized older medical patients: a systematic review. J Clin Epidemiol 64:619\u2013627","journal-title":"J Clin Epidemiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08877-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T04:22:59Z","timestamp":1729311779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08877-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["8877"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08877-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the University of Rochester Medical Center Institutional Review Board (IRB). All participating practice clusters obtained approval from their institutional review boards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"674"}}